Dipeptidyl peptidase IV (DP WEC 3.4.14.5) was localized in endocrine cells of pig panaeas by immunohistochemical and enzyme histochemical methods. Immunolight microscopy with both monoclonal and polydonal antibodies demonstrated DP IV immunoreactivity in cells located in the peripheral part of the islets of Langerhans. The antigen is enzymatically active, as shown by enzyme histochemical analysis with a synthetic DP IV substrate. By immunoelectron microscopy (immunogold labeling), the labeling of DP IV in the islets was associated with the seaetory granules of the A-cells, as identified by double labeling using a mono-' Supported by the Lundbeck Foundation, the NOVO Foundation, and the Danish Medical Research Council (12-7142). The project was part of a program under the clonal glucagon antibody as the second primary antibody.
Introduction
It is known that the intracellular transport of proteins destined for secretory granules, the plasma membrane, the lysosomes, the endoplasmic reticulum (ER), or the Golgi compartments occurs via the secretory pathway (Pfeffer and Rothman, 1987) . At present, available data are consistent with a model in which constitutive secretion occurs by a default mechanism (Rothman, 1987) : proteins competent for entry into the ER (Blobel and Dobberstein, 1975) but lacking any additional sorting information transit from the ER to the Golgi complex and then to the surface via a nonspecific bulkflow mechanism. Proteins that exit from this pathway, such as regulated secretory proteins and lysosomal enzymes, contain additional sorting signals that permit specific recognition, modification, and subsequent delivery to the correct destinations (Pfeffer and Rothman, 1987) .
Dipeptidyl peptidase IV (DP IV) is a serine exopeptidase which preferentially cleaves N-terminal amino acyl-proline and amino acylalanine dipeptides from a variety of oligopeptides (Heins et al., 1988) . This enzyme has been purified from various sources, e.g., pig kidney (Kenny et al., 1976) and pig small intestine (Svensson et al., 1978) , where it is found in high amounts in the brush border membranes ofthe proximal tubule cells and enterocytes, respectively. However, many other tissues also express DP IV activity (Hartel et al., 1988) . The CD 26 activation marker on the surface of IL2producing T-lymphocytes is identical to DP IV (Ulmer et al., 1990) .
The physiological roles played by DP IV are not fully understood but several possible functions have been proposed, such as final digestion of peptides present in the small intestinal luminal contents (Svensson et al., 1978) , activation of T-lymphocytes (Schon et al., 1989) , and activation andlor inactivation of biologically active peptides (Nausch et al., 1990; Mentlein, 1988) . Thus, stepwise release of dipeptides by DP IV as a late step in the generation of peptides from their precursors has been observed in different organisms such as yeast (Fuller et al., 1988) , insects (Kreil et al., 1980) , and frogs (Mollay et al., 1986) .
The wide distribution of DP IV, together with the various physiological roles suggested for this enzyme, prompted us to investigate whether its subcellular localization might vary among different cell types. It is well known that DP IV is found in the apical plasma membrane of epithelial cells, and it has been demonstrated in secretory granules of some exocrine cell types (Gossrau, 1981) . However, its possible role as a processing enzyme suggests that it might also occur in secretory granules of endocrine cells. An immunocytochemical investigation on the occurrence of DP IV in various endocrine 81 organs of the pig showed that DP IV actually occurs in the secretory granules of glucagon-producing endocrine cells of the pancreas and intestine. The sorting of identical or closely related proteins to drfferent organelles in different cell types constitutes a basis for future investigations on potential sorting signals.
Materials and Methods
Tissue. Pig pancreas and pig small intestine were kindly provided by the Department of Experimental Pathology, Rigshospitalet, Copenhagen, Denmark.
Materials. Epon TAAB 812 Resin lclt was a product of TAAB Laboratories Equipment (Berkshire, UK). Tissue-Tek was purchased from Kunz Instruments (Copenhagen, Denmark). Aprotinin was purchased from NOVO Nordisk (Bagmd, Denmark), Diprotin A (L-isoleucyl-L-prolyl-L-isoleucine), leupeptin, and glycyl-~-proline-4-methoxy-P-naphthylamide x 2 HzO were obtained from Bachem (Liestal, Switzerland). CNBr-activated Sepharose 4B was purchased from Pharmacia (Hillerpd. Denmark). HSA agarose was a product of Litex (Vallensbaek Strand, Denmark), and tannic acid was a product of Mallinckrodt (St. Louis, MO). The chloroauric acid was obtained from Merck (Darmstadt. Germany). All other chemicals used were of analytical grade and were purchased from Sigma.
Antibodies. Monoclonal antibodies (MAb) to glucagon (GLU-001) and insulin were a generous gift from NOVO Nordisk. The rat MAb 4H3 against human small intestinal brush border DP IV was produced by Gorvel et al. (1991) . MAb 4H3 specifically immunoprecipitated DP IV from a Triton X-100-solubilized brush border membrane preparation, as shown by N-terminal sequencing of the precipitated antigen. Swine anti-rabbit IgG conjugated to fluorescein isothiocyanate (FIE) or horseradish peroxidase (HRP). respectively, and rabbit anti-rat IgG conjugated to F I X were purchased from Dakopatts (Glostrup, Denmark). Sheep anti-rabbit IgG was from Statens Bakteriologiska Laboratorium (Stockholm, Sweden). The rabbit polyclonal antibody 1069 against pig small intestinal brush border DP IV was produced by Svensson et al. (1978) . 1069 ads was prepared by negative immunoadsorption of protein A-Sepharose-purified 1069 IgG as follows: approximately 5 ml1069 IgG (8.8 mglml), previously dialyzed against 0.2 M sodium citrate, pH 6.5, was coupled to 3.5 ml CNBr-activated Sepharose 48 gel suspension in an end-over-end mixer for 2 hr at room temperature.
T h e gel was packed in a 5-ml syringe equipped with a filter in the bottom. The column was washed overnight in TBS (0.05 M Tris-HC1,O.lS M NaCI), pH 8.0, before use. Ten ml of a Triton X-100-solubilized microvillar preparation (675 pg proteinlml), prepared according to Kessler et al. (1978) as described by Sjostrom et al. (1980) , were applied to the immunoadsorbent column. Fractions containing the non-adsorbed material, and thus depleted of DP IV activity, were coupled to another Sepharose 4B column by the same procedure. Five ml 1069 IgG were applied to the column. The nonadsorbed fraction, constituting the purified 1069 IgG (1069 ads), was subsequently used in immunoblotting experiments to analyze its reactivity against proteins, previously immunoadsorbent-purified with the 1069 antibody, from an intestinal microvillar preparation and a pancreas homogenate DreDaration.
Panaeas Homogenate Preparation. All preparative steps were performed at 4'C. Ten g frozen pancreas tissue were homogenized in 25 ml TBS, pH 8.0, containing 2 pglml aprotinin and 5 mM EDTA in aDounce homogenizer and were centrifuged at 1000 x g for 15 min. The supernatant was subsequently solubilized in Triton X-100 (final concentration 2%) on a mag netic stirrer for 1 hr. The solubilized homogenate was finally centrifuged at 80,000 x g for 1 hr and the supernatant fraction was stored at -20°C.
Immunoadsorption. DP IV was immunoadsorbent-purified from the pancreas homogenate preparation and from an intestinal microvillar prep-aration using a 50O-pl Sepharose 4B column to which antibody 1069 was conjugated.
Immunoblotting. Reduced samples were subjected to SDS-PAGE (Laemmli, 1970) in 10% gels and transferred to nitrocellulose membrane BA 45 (Schleicher & Schuell; Dassell, Germany) by electrophoresis in a semidry blotting cell (Kyhse-Andersen, 1984) . The nitrocellulose membrane was subsequently soaked in PBS (0.1 M sodium phosphate, 0.15 M NaCI), pH 7.4, containing 5% skim milk powder for 2 hr and overnight in appropriately diluted primary antibody in PBS containing 0.05 % Tween-20. After a thorough wash in PBS containing 2.5% skim milk powder, the nitrocellulose membrane was incubated for 2 hr with the HRP-conjugated anti-rabbit IgG diluted 1:400 in PBS containing 0.05% Tween-20. Finally, the immunoblot was enzymatically stained with 3-amino-9-ethylcarbazole as the substrate.
Light Mi a".
Pieces of pig pancreas and pig small intestine (4 mm) were fivcd in modified Bouin's fixative [ 2 % paraformaldehyde and 15 % picric acid (2,4,6-trinitrophenol)] in PBS, pH 7.2, for 24 hr at 4'C, then dehydrated in agraded series of ethanol and successively soaked in methylbenzoate and benzene. Finally, the pieces were embedded in paraffin and cut in 2-pm sections on a conventional microtome Uung). The sections were collected on chromalum-covered glass slides. Paraffin was removed from the sections by toluene and the sections were rehydrated.
Immunofluorescence Labeling. All incubations and rinsing procedures were performed in teleostean gelatin solution (0.05 M Tris-HC1 buffer, pH 7.4, containing0.5% ovalbumin, 0.1% gelatin, 0.5% Tween-20,0.2% teleostean gelatin). To minimize nonspecific antibody adsorption, the sections were incubated in teleostean gelatin solution for 20 min at room temperature before the immunolabeling. Sections were incubated with 1069 ads or with 4H3 for 20 hr at 4'C. followed by 1 hr at room temperature, and then were rinsed. Bound antibodies were detected after incubation with FIE-conjugated anti-rabbit or anti-mouse IgG (F 205 and F 234, respectively) for 30 min at room temperature. The sections were examined in a Zeiss epifluorescence microscope equipped with intemrence filters for FIX (Optisk Laboratorium; Lundtofte, Denmark) . Control experiments omitting the primary antibody were performed. Electron Microscopy. Gold particles of 7. 10, and 12 nm were prepared according to the tannic acid method described by Slot and Geuze (1985) . The gold particles were conjugated to protein A as described by Balslev and Hansen (1989) or to sheep anti-rabbit IgG as described by Hansen et al. (1992) .
Immunogold labeling with IgG-gold complexes was carried out as previously described by Hansen et al. (1989) .
Immunogold double labeling was carried out as follows: all incubations were performed in Tris-HCI-Triton buffer solution (0.05 M Tris-HC1, 0.15 M NaCI, 1% Triton X-loo), pH 7.4, or in gold buffer (0.02 M %is-HCI, 0.15 M NaCI, 1% Triton X-100, 0.25% BSA), pH 8.2, in a moist chamber at room temperature unless otherwise stated. All solutions were filtered (Acrodisc 0.2 pm; Gelman Sciences; Ann Arbor, MI).
The sections were treated with 1% hydrogen peroxide in water for S min, rinsed in Tris-HC1-Triton buffer, treated with 6% BSA in gold buffer for 30 min. and finally rinsed in gold buffer. The sections were then incubated with DP IV antibody 1069 appropriately diluted in gold buffer for 20 hr at 4'C and 2 hr at room temperature, rinsed, and incubated with protein A conjugated to 12-nm gold particles (previously centrifuged at 3000 x g for 3 min). After a rinse in gold buffer (three times for 10 min), the sections were immersed in Tris-HC1-Triton buffer containing 0.2 mglml unlabeled protein A for 45 min and rinsed in gold buffer. Thereafter, a second labeling was performed after the same procedure as described above, except that the glucagon antibody GLU-001 (diluted 1:500 in gold buffer) was used as the primary antibody and protein A was conjugated to 7-nm gold particles. The sections were contrasted in 1% uranyl acetate in water for 8 min in the dark and subsequently in lead citrate (Reynolds, 1963) for 3 min. The sections were examined in a Philips EM 201c or a Zeis EM 900.
Three different control experiments were carried out: (a) omission of the primary antibody; (b) adsorption of the primary antibody: 100 p1 1069 (8.8 mglml) were mixed with 500 pl purified intestinal DP IV (150 pglml) and incubated for 48 hr at 4'C. The mixture was subscqucntly tested for labeling capacity at a final dilution of 1:lOO; and (c) elimination of DP IV-reacting antibodies from 1069: 20 portions of 100 p1 1069 (8.8 mg/ml) were applied to a 200-pl column composed of intestinal DP IV conjugated to Sepharose, prepared as described by the manufacturer. The efflux was collected in 300-400-pl fractions. In the first fractions there was no immunoreactivity as tested by immunoblotting against purified intestinal DP IV. In later fractions the immunoreactivity gradually increased.
Enzyme Histochemistry. Pieces of pig pancreas (5 mm) were frozen in -70°C hexane for 1 min. The tissue blocks were mounted on a previously cooled cryostat table with Tissue-Tek and were cut in 8-pm sections in a Bright cryostat at -25'C. The sections were incubated at 37'C for 30 min in a freshly prepared medium containing 1.5 mM Gly-~-Pro-4-methoxy-Pnaphthylamide dissolved in 50 pl N.N-dimethylformamidc in 0.05 M sodium phosphate buffer, pH 7.5. containing 2.8 pg/ml aprotinin. 
Results

Antibody Specz-city
The DP IV antibody 1069 raised against native pig small intestinal DP IV, prepared as described by Svensson et al. (1978) and further purified by negative immunoadsorption as described in Materials 1069 ads (Figure 4) and a combination of 1069 and glucagon antibodies (Figure 5 ) clearly demonstrated that DP IV immunoreactivity in the islets of Langerhans is associated with the secretory granules in the A-cells. I I and Methods, was analyzed by immunoblotting against immunoadsorbent-purified DP IV from an intestinal brush border preparation and from a pancreas homogenate preparation (Figure 1 ). The antibody reacted with a single protein band of approximately 130 KD in both the intestinal DP IV preparation (Lane a) and the pancreatic DP IV preparation (Lane c). The molecular weight of the pancreas enzyme corresponds to that reported earlier for intestinal DP IV (Svensson et al., 1978) . Figure 2 shows the localization of DP IV in enterocytes of the small intestine. Like other polarized epithelial cells expressing DP IV, the villar enterocytes sort DP IV to the apical plasma membrane. In the pancreas, DP IV was seen in endocrine as well as in exocrine parts of the organ (Figure 3) . Indirect immunofluorescence based on both polyclonal (Figure 3a ) and monoclonal (Figure 3b ) antibodies showed DP IV immunoreactivity in a subpopulation of the cells in the islets of Langerhans. In the exocrine part, fairly intense immunoreactivity appeared in the capillary endothelium, whereas a faint reactivity could be observed in acini and excretory ducts. When the primary antibodies were omitted no fluorescence could be detected in any part of the tissue.
Immunolight Microscopy
Fiqure 2. Localization of DP IV in the small intestine by indirect immunofluorebcence using the antibody 1069 ads. DP IV immunoreactivity is mainly localized to the apical plasma membrane of the villous enterocytes (arrowhead), but is also weakly present in the basolateral membrane (arrows). Bar = 50 Pm.
Immunoekctron Microscopy
The results obtained by immunogold labeling with the antibody To determine whether the DP IV immunoreactivity also occurs in secretory granules of intestinal glucagon-producing cells (Lcells), a double labeling experiment was also performed on the small intestine ( Figure 6 ). The result showed that DP IV immunoreactivity is associated with the secretory granules of Lcells in the small intestine as well.
To examine the significance of the obtained DP IV immunolabeling, control experiments were carried out in which the primary antibody 1069 was omitted or had been pre-incubated with purified intestinal microvillar DP IV. Incubation of such control sections with sheep anti-rabbit IgG conjugated to gold particles showed no staining in the islet A-cell secretory granules (results not shown). An additional control experiment was performed with different pools of 1069 that had been depleted of DP IV-reacting antibodies by immunoadsorption as described in Materials and Methods. When an early fraction of the efflux was used for immunolabeling no significant immunoreactivity could be detected in the secretory gran- Figure 5 . Protein A-gold double labeling of islet cells performed with antibodies directed against DP IV (1069) (12-nm gold particles) and glucagon (%nm gold particles). The co-localization of glucagon and DP IV (arrow) demonstrates the localization of DP IV to the secretory granules of Acells. The differentappearing granules in the lower half of the picture (arrowhead) belong to a neighboring cell. An experiment carried out in parallel with monoclonal antibodies directed against insulin showed that this cell is a Bcell. Bar = 200 nm. ules (Figure 7) . Conversely, when a late fraction was used the labeling capacity of the antibody almost totally resumed.
The results show that gold particles representing DP IV are scattered all over the granules and are not specifically associated with the secretory granule membrane, as would have been the case if the protein is membrane bound. Therefore, the results suggest that DP IV in secretory granules is a soluble protein.
Enzyme Histochemistry
The result of the enzyme histochemical staining of pig pancreas clearly demonstrated the presence of DP IV activity in about 2 5 % of the cells in the islets of Langerhans (Figure 8 ) and therefore is in line with the immunohistochemical localization of DP IV to islet A-cells. Figure 6 . Protein A-gold double labeling performed on pig small intestine with primary antibodies directed against DP IV (1069) and glucagon (GLU-001). Colocalization of glucagon (7-nm gold particles) and DP IV (12-nm gold particles) is observed in the secretory granules of an endocrine glucagon-producing cell (L-cell). Bar = 200 nm.
Omission of the Gly-~-Pro-4-methoxy-P-naphthylamide substrate or addition of Diprotin A, an inhibitor of Gly-~-Pro-4methoxy-P-naphthylamidase activity (Rahfeld et al., 1991) . to the incubation media completely abolished the activity (results not shown).
Discussion
We have localized DP IV to the secretory granules of glucagonproducing cells of the pancreas (A-cells) and of the small intestine (Lcells). Since DP IV is known to be an apical plasma membrane protein in various polarized epithelial cells (e.g., kidney proximal tubule cells, the fully differentiated small intestinal enterocyte, and the exocrine acinar cells of the pancreas), the present study clearly shows that the same or a very similar protein is sorted to secretory granules in A-and Lcells. This implies that the secretory granule DP IV and the membrane bound apical plasma membrane DP IV are endowed with different sorting signals and/or that the cellular sorting machinery is cell type specific. Alternatively, transport either to the apical plasma membrane or to the secretory granules occurs by default.
It is generally assumed that sorting of proteins to secretory granules is accomplished by specific receptors (Burgess and Kelly, 1987) ; a set of proteins from dog pancreatic tissue that exhibit properties expected of sorting carriers for regulated secretory proteins has been isolated and proposed to be the long sought so-called sortases (Chung et al., 1989) . Furthermore, because pancreatic acinar cells, which have both regulated and constitutive pathways, express DP IV solely in their apical plasma membranes, it might be that both the secretory granule DP IV and DP IV localized in the apical plasma membrane are actively sorted. Accordingly, the existence of specific sorting signals and/or corresponding receptors is suggested to be responsible. This hypothesis was originally proposed by Bartles and Hubbard (1988) in view of the differences between hepato- cytes and MDCK cells with respect to the mechanism of protein sorting to apical and basolateral plasma membranes.
The immunoelectron microscopic results indicate that the secretory granule DP IV is a soluble protein, as the labeling is seen all over the granules; the size of an antibody molecule (-8 nm) and of an A-cell secretory granule (-250 nm) implies that gold particles would localize close to the granule membrane if the enzyme under study is membrane bound. This is supported by a recent endocytosis study on lactase, another intestinal microvillar protein, in which immunogold labeling of newly endocytosed lactase in newborn pigs is restricted to the membrane of the endosomes (G. H. Hansen, unpublished observations) . Soluble forms of DP IV (Weisz et al., 1991) and another microvillar membrane enzyme, aminopeptidase N (Vogel et al., 1992) , have been generated, and it has been demonstrated that these forms after transfection into MDCK cells are constitutively secreted from the apical membrane. Therefore, soluble forms of these enzymes can also be directed to constitutively secreted vesicles.
Immunoblot analysis of the specificity of the antibody 1069 ads against proteins immunoadsorbent-purified from a pancreas prep-aration and from an intestinal brush border preparation showed only one protein band. This band represented a protein of approximately 130 KD which corresponds to a previously determined molecular weight for DP IV isolated from intestinal brush border membranes. Therefore, the molecular weight of pancreatic DP IV is identical or very similar to the intestinal brush border DP IV protein.
An interesting aspect in relation to our localization of D P IV in secretory granules is the suggestion that DP IV plays a role in the activation andlor inactivation of biologically active peptides. Thus, pancreatic polypeptide which has been localized to secretory granules in A-cells in the mouse pancreas (Rombout et al., 1987) has recently been shown to be a substrate of DP IV (Nausch et al., 1990) . Furthermore, cholecystokinin-pancreozymin, B-neoendorphin, dynorphin, and an a-endorphine-like peptide all have been immunochemically localized to pancreatic A-cells in the rat (Cetin, 1985; Grube et al., 1978) . Proteolytic processing of prohormones is often initiated by an endopeptidase which splits the immature protein at pairs of basic amino acids (e.g.. Lys-Lys or Lys-Arg), followed by exopeptidase trimming at amino-and carboxyterminal ends. A family of carboxypeptidases are known to process carboxy-terminal ends of pro-hormones (Grimwood et al., 1989) . By analogy, DP IV, or a DP IV-like enzyme, might belong to a family of peptidases involved in the processing of N-terminal ends of pro-hormones. Moreover, most processing enzymes, also enzymes of low substrate specificity, are not able to cleave at, or near, proline residues, and therefore the unique specificity of DP IV for amino acyl-proline sequences might confer a regulatory role for DP IV.
The dlfferent localizations of DP IV in different cell types constitute a basis for further studies on its sorting. Detailed studies on the molecular structure of DP IV from A-cells and comparison to DP IV from enterocytes might lead to the identification of the putative sorting signals that are suggested to constitute the basis for correct sorting of DP IV to A-cell secretory granules and/or to the apical plasma membrane of enterocytes.
